Abstract:Inflammation plays a key role in the development and progression of cancers. Inhibition of inflammation will prevent carcinogenesis. Cancer and inflammation are linked by two pathways. The extrinsic pathway can be activated by inflammation or infection and the activation of the intrinsic pathway can be caused by oncogene activation. The two pathways co‐activate the transcription factors. The neutrophils are important part of the pathways. Previously, we had found that curcumin upregulated α1‐AT in cancer tissue, which is an endogenous inhibitor of neutrophil elastase (NE). Neutrophils and cancer cells are similar in character.Firstly, we used the C57 mouse bearing lung cancer model to observe the effect of EGCG on cancer. EGCG could prolong the survival time of cancer mice, reduce cancer volume. At a lower dose of EGCG showed a significantly reduction on the number of metastases in lung tissue and reduced the MPO activity as well. EGCG reversed the migration of NE‐induced A549 cells, and inhibited the activity of NE in a dose‐dependent manner. Using 2D‐MS, we examined the differential protein profiling of EGCG in mouse cancer tissue and detected 12 differential proteins. Signal pathway enrichment analysis by ToppCluster indicated that the PI3K‐Akt‐mTOR signal pathway had the best network correlation. And the IRS‐1, NE substrate and 14‐3‐3e in the network had higher score than other proteins. EGCG up‐regulated α1‐AT, IRS‐1, inhibited PI3K/Akt. Molecular docking and SPR results revealed that EGCG could dosedependently bind to NE. In addition, we had found that curcumin antagonized α1‐AT mRNA levels and up‐regulates the activity of the α1‐AT promoter, indicating that the expression of α1‐AT is regulated at the transcriptional level. Moreover, molecular docking results showed that curcumin also dose‐dependently bound to NE. Our study shows that EGCG and curcumin may have a certain inhibitory effect on inflammation‐related cancers, and the mechanism is related to their up‐regulation on α1‐AT and their inhibition on NE, the both may be the potential drug target for cancer prevention and treatment.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Dietary polyphenols, inflammation, and cancer.

Targeting NF-κB signaling pathway in cancer by dietary polyphenols

Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer

Dietary Cancer Chemopreventive Agents - Targeting Inflammation And Nrf2 Signaling Pathway

Id‐1 promotes proliferation of p53‐deficient esophageal cancer cells

Modulation of the Canonical Wnt Signaling Pathway by Dietary Polyphenols, an Opportunity for Colorectal Cancer Chemoprevention and Treatment

[Qualitative and quantitative scintigraphic diagnosis of a fresh ischemic myocardial lesion with 99mTc-pyrophosphate].

Natural Polyphenols for Prevention and Treatment of Cancer

Polyphenols as Immunomodulators and Epigenetic Modulators: An Analysis of Their Role in the Treatment and Prevention of Breast Cancer

Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer

Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms

Effect and Mechanism of Several Polyphenols on Inflammation Related Cancers

Some Important Dietary Polyphenolic Compounds: An Anti-inflammatory and Immunoregulatory Perspective

From Inflammation to Cancer: the Molecular Basis

The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis

Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment

Cancer and diet: How are they related?

[Value of induced sputum in the investigation of asthma].

Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention

Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment

Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease